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Purpose: In the C57BL/6J mouse retina, hyperoxia-induced degeneration of photoreceptors shows strong regional
variation, beginning at a locus ~0.5 mm inferior to the optic disc. To identify gene expression differences that might
underlie this variability in vulnerability, we have used microarray techniques to describe regional (superior-inferior)
variations in gene expression in the retina.
Methods: Young adult C57BL/6J mice raised in dim cyclic illumination (12 h at 5 lx and 12 h in darkness) were exposed
to hyperoxia (75% oxygen for two weeks). Retinas were collected from hyperoxia-exposed and control animals without
fixation and divided into superior and inferior halves. RNA was extracted from each sample, purified, and hybridized to
Mouse Gene 1.0 ST arrays (Affymetrix). The consistency of the microarray results was assessed using quantitative PCR
for selected genes. Expression data were analyzed to identify genes and ncRNAs whose differential expression between
the superior and inferior retina could be associated with relative vulnerability to hyperoxia.
Results: In control retinas, only two genes showed a fold difference in expression >2 between the superior and inferior
retina; another 25 showed a fold difference of 1.5–2.0. Of these 27, the functions of six genes, including ventral anterior
homeobox containing gene 2 (Vax2) and T-box 5 (Tbox5), are related to parameters of anatomic development and the
functions of five are related to sensory perception. Among the latter, short-wave-sensitive cone opsin (Opn1sw) was more
strongly expressed in the inferior retina and medium-wave-sensitive cone opsin (Opn1mw) in the superior retina. This is
consistent with known differences in S- and M-cone distribution, confirming our separation of retinal regions. The highest
fold difference was reported for membrane metalloendopeptidase (Mme), a member from the metallothionein group of
cytoprotective proteins. To identify genes whose regulation by hyperoxia was significantly different between the inferior
and superior retina, we calculated the “fold margin” (FM, the difference between hyperoxia-induced regulation in the
inferior and superior retina) for each gene, and identified genes for which abs(FM) > 0.5. Genes thus identified numbered
112, and included many immune-, cell defense-, and inflammation- related genes.
Conclusions: Gene expression analysis revealed relatively subtle differences between inferior and superior regions of
control C57BL/6J retinas, with only 27 genes showing an expression difference >1.5 fold. Among these, genes related to
cytoprotection and apoptosis were included, along with genes related to central projections and cone-type differences.
After hyperoxia-induced photoreceptor degeneration had begun, the number of genes that showed significant expression
differences between the inferior and superior retina more than quadrupled, with genes related to immune processes, defense
processes, and inflammation being numerically dominant.
Tissue  oxygen  levels  play  an  important  role  in  the
development  of  the  retina  and  in  the  stability  of
photoreceptors. During development, the retina is initially
avascular  and  is  supplied  with  oxygen  by  diffusion  from
choroidal  circulation.  As  photoreceptors  develop  and
commence functioning in rodents during the second week of
postnatal  life  [1],  their  consumption  of  oxygen  increases
steeply  and  their  retinas  become  hypoxic.  The  onset  of
hypoxia is the stimulus for vasculogenesis [2], mediated by
the potent hypoxia-induced angiogenic vascular endothelial
growth factor (VEGF) [3]. The formation of retinal vessels
relieves  the  hypoxia  induced  by  photoreceptor  activity.
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During this period, oxygen regulates a naturally occurring
process  of  photoreceptor  death  in  a  linear  way,  hypoxia
accelerating  and  hyperoxia  decelerating  the  rate  at  which
photoreceptors die [4]. As retinas mature, however, hyperoxia
becomes  toxic;  both  hypoxia  and  hyperoxia  destabilize
photoreceptors  [5].  The  toxic  impact  of  hyperoxia  on
photoreceptors  was  first  reported  in  adult  rabbits  [6]  and
subsequently in rodents [7,8]. Hyperoxia also induces the
death  of  endothelial  cells  and  the  thinning  of  retinal
vasculature and reduces VEGF expression (thus the opposite
of the angiogenic effect of hypoxia) [9].
There is also evidence that hyperoxia can improve the
stability  of  photoreceptors.  In  experimental  retinal
detachment, hypoxia caused by the separation of the outer
retina  from  its  normal  source  of  nutrients  is  a  factor  in
inducing the death and deconstruction of photoreceptors, as
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740well as in reducing glial proliferation. Hyperoxia mitigates all
these pathologies [10,11]. Hyperbaric oxygen therapy (HBO),
which  involves  very  high  tissue  oxygen  levels  for  short
periods, has been reported to have long-lasting benefits for
patients  with  retinitis  pigmentosa  [12]  and  several  other
ophthalmic  diseases,  including  glaucoma,  macular
detachment, and neovascular disease [13]. In recent work
undertaken to resolve this apparent discrepancy [8,14], we
have  noted  that  the  impact  of  hyperoxia  on  retinal  gene
expression is biphasic, initially regulating protective genes
and later regulating genes related to photoreceptor death. This
suggests that hyperbaric oxygen protects the retina because it
is produced briefly, typically lasting only a few hours a day,
and may regulate only the protective cohort of genes.
This  study  probes  the  mechanism  of  oxygen-induced
destabilization  of  photoreceptors  by  exploiting  known
regional  differences  in  photoreceptor  vulnerability.  A
superior-inferior  gradient  of  vulnerability  is  evident  for
hyperoxia, which in C57BL/6J mice affects photoreceptors in
the inferior retina more severely [14,15]. Other works have
described  a  periphero-central  gradient  in  photoreceptor
vulnerability  to  hyperoxia,  both  hyperbaric  [16]  and
normobaric [7]. It is possible that these researchers noted the
central location of vulnerable photoreceptors, without noting
whether they were located in the superior or inferior retina.
Several gradients of vulnerability of the retina have been
previously  reported.  For  example,  light-induced  retinal
damage can be more severe in the superior retina than the
inferior retina of albino rats [17,18]. Degeneration induced by
the photoreceptor toxin iodoacetic acid is more severe in the
inferior retina and visual streak of rabbit retinas [19] and, in
a genetically degenerative mouse model (the rd/rd mouse),
significantly more cones survive in the inferior than superior
hemisphere in most retinas [20]. Although various factors,
such  as  light  history,  rhodopsin  content,  and  fatty  acid
composition have been reported to influence the vulnerability
of photoreceptors to damage, the mechanisms responsible for
regional  variations  of  photoreceptor  vulnerability  to
hyperoxia remain unknown.
METHODS
Animals  and  hyperoxic  damage:  C57BL/6J  mice,  a
hyperoxia-vulnerable strain [21], were used for this study.
Mice were raised in dim cyclic illumination (12 h at 5 lx and
12 h in dark) and maintained in this level of lighting for the
duration of the experiment. At the postnatal age (P) of P83–
P90 days, some mice were exposed to constant hyperoxia
(75% O2) for 14 days. During exposure, the mice were given
free access to food and water and were housed in plexiglass
chambers, in which the oxygen level was controlled by a
feedback  device  (OxyCycler;  Reming  Bioinstruments,
Redfield, NY).
RNA  isolation  and  purification:  Oxygen-exposed  animals
were euthanized at the end of the period of hyperoxia; controls
were euthanized at the same age. Retinas were removed and
divided into superior and inferior halves. Retinal samples
from two animals (one male and one female) were pooled for
each condition (superior and inferior retina from the controls,
superior and inferior retina exposed). RNA extraction was
performed  using  TRIzol  Reagent  (Invitrogen™  Life
Technologies, Carlsbad, CA) and an RNAqueous-Micro Kit
(Ambion, Foster City, CA). TRIzol was used to isolate the
RNA and the RNAqueous-Micro Kit was used to purify and
DNase-treat the RNA. Retinas were quickly placed into a
1.5  ml  tube  containing  200  µl  of  TRIzol.  Following  the
homogenization of retinas on ice, a further 660 µl of TRIzol
and 160 µl of chloroform were added to the tube. The tube
was vortexed for 20 s and allowed to stand for 7 min at room
temperature. The tubes were centrifuged at 13,000× g for 10
min at 4 °C. The supernatant was then removed and placed
into a clean 1.5 ml tube with half its volume of 100% ethanol.
The tube was vortexed briefly before the contents underwent
purification  and  DNase  treatment,  as  detailed  in  the
RNAqueous-Micro  Kit  manual.  Purified  DNAase-treated
RNA  was  analyzed  using  a  ND-1000  spectrophotometer
(NanoDrop  Technologies,  Wilmington,  DE)  and  a  2100
Bioanalyzer  (Agilent  Technologies,  Santa  Clara,  CA),  to
determine  the  quantity  and  quality  of  the  sample.  RNA
samples were used only if the A260/A280 ratio was above 1.9
and the RIN (RNA integrity number) was greater than 8.5.
Affymetrix microarray analysis: The Affymetrix (Santa Clara,
CA) Mouse Gene 1.0 ST Array was used; this is a whole
transcript-based array that interrogates 28,853 well annotated
genes. Staining, hybridization, washing, and scanning of the
array were performed at the Biomolecular Resource Facility
at the John Curtin School of Medical Research, Australian
National  University,  following  manufacturers’  protocols.
Two  experimental  replicates  were  run  independently,
providing duplicates for each condition. Gene expression data
were stored in .cel format files that could be interpreted by
array analysis software.
Quality  assessment  and  hierarchical  clustering:
Affymetrix®  Expression  Console™  software  was  used  to
supply  probe  set  summarization  and  calculate  quality
assessment metrics. Gene expression data were uploaded into
the Expression Console™ software to run a gene level core
analysis. Once the analysis was complete, the numeric values
of quality control metrics were summarized in a report and
visualized in line graphs. Hierarchical clustering of data sets
was performed using the heat map function in the Partek
Genomics Suite (Partek Inc., St. Louis, MO). It uses log2
signal values. The following parameter settings were used:
Method  -  average  linkage;  Dissimilarity  -  Euclidean;
Clustering method-agglomerative.
Statistical analysis: Gene expression files in .cel format were
imported into the Partek Genomics Suite, with the following
normalization  of  their  configuration:  Probes  to  import  -
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Background correction - RMA background; Log base - 2;
Probe  set  summarization  -  Median  Polish.  Statistical
differences  between  experimental  groups  were  examined
using a t-test (post-hoc contrasts).
Gene  expression  in  the  inferior  and  superior  regions  of
control retinas: Gene expression was compared between the
superior  and  inferior  regions  of  the  control  retinas  using
statistical and fold change analysis. In this comparison, there
was  no  experimental  procedure  applied;  therefore,  the
conventional term “fold change” seems inappropriate. Instead
we use “fold difference.” Fold difference (FD) is then:
FD=E2/E1 when expression is greater in the second of
two experimental (E) samples, FD=- E1/E2, when expression
in the second sample is less.
In these equations, E1 is the level of expression in the first
(usually the control) sample, and E2 is the level in the second
(usually  treated)  sample.  To  apply  this  convention  to  the
present samples, we chose the inferior retina as sample 2 (E2)
and the superior retina as sample 1 (E1).
Data were then analyzed using two-sample t-tests for
significant differences (increases and decreases) between the
inferior and superior retina in the expression of all probes.
Gene  expression  in  the  inferior  and  superior  regions  of
hyperoxia-exposed  retinas:  To  identify  such  genes,  we
analyzed the four samples arising from the two variables in
this part of the study: treatment (hyperoxia versus control) and
site (inferior versus superior). Each sample was available in
duplicate. A 2-way ANOVA test applied to the eight data sets
provided  three  p  values  for  each  gene,  one  giving  the
probability that the gene was not regulated by hyperoxia in
the superior retina, the second giving the probability that the
gene was not regulated in the inferior retina, and the third (the
“combination” p value) giving the probability that the gene
was not regulated in either region. For each gene, there were
also available twofold ratio values, one that indicated the
change in its expression induced by hyperoxia in the inferior
retina, and a second that indicated the change in expression in
the superior retina.
To identify genes regulated differently by hyperoxia in
the  two  regions,  we  selected  genes  for  which  the  2-way
ANOVA test gave a combination p value <0.05. Then we
developed a specific measure of expression difference, called
“fold margin” (FM).
We calculated a FM value for each gene, FM=FRi – FRs
where FM is the fold margin, FRi is the fold ratio for that gene
in the inferior retina, and FRs are the fold ratios for that gene
in the superior retina.
Functional analysis: Analysis of gene ontology and molecular
pathways was performed using the bioinformatics resource
Database  for  Annotation,  Visualization  and  Integrated
Discovery (DAVID) and Ingenuity Pathway Analysis (IPA)
software (Ingenuity Systems Inc., Redwood City, CA). Using
the Ingenuity Pathways Knowledge Base, IPA Core Analysis
tools were used to assign genes to the most significant known
molecular networks and biologic processes.
Quantitative polymerase chain reaction: Quantitative PCR
(qPCR)  was  used  to  validate  the  expression  changes  of
selected genes identified in the microarray experiment. Three
biologic replicates were used for each condition; RNA was
processed as for the microarray experiments. For each sample,
1 µg retinal RNA was reverse transcribed into cDNA using
the  Superscript  III  Reverse  Transcriptase  protocol.  The
resulting cDNA sample served as a template for real time
qPCR using TaqMan® probes and accompanying Master Mix
(Applied  Biosystems,  Foster  City,  CA).  A  typical  20  µl
reaction is composed of 10 µl 2× TaqMan Gene Expression
Master Mix, 1 µl TaqMan Gene Expression Assay, 0.4 µl
cDNA templates and RNase-free water. All reactions were set
up in duplicate and negative controls without any template or
probe were included. The qPCR was performed on a Rotor-
Gene 3000 and analyzed using the Rotor-Gene 6 software
(Corbett  Robotics,  Mortlake,  NSW,  Australia).  A  typical
qPCR program was used, including 2 min incubation at 50 °C
and 10 min enzyme activation at 95 °C, followed by 40 cycles
of 15 s denaturation at 95 °C plus 1 min probe annealing at
60  °C.  The  Ct  (cycle  threshold)  means,  representing  the
quantitation of the amount of cDNA in the original sample,
were used to calculate fold change using the Pfaffl Equation
[22]. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH)
was  employed  as  a  reference  gene  against  which  relative
expression values of other genes were calculated.
RESULTS
Clustering  analysis:  Hierarchical  clustering  analysis  was
performed using the heat map function in the Partek Genomics
Suite (Figure 1). The replicates of each group clustered most
closely to each other (GEO accession number GSE21246) and
were  therefore  averaged;  Figure  1  therefore  shows  the
clustering of the averaged samples. Superior retina samples
before and after hyperoxia clustered more closely to each
other than to other groups, indicating that hyperoxia had little
effect on the superior retina. Gene expression in the inferior
retina  diverged  from  the  superior  retina,  with  hyperoxia
increasing the separation.
Control retina: genes differently expressed in inferior and
superior regions: Comparison of gene expression levels in
inferior  and  superior  regions  of  control  retinas  identified
expression changes in a limited cohort of sequences.
Identification:  The  FD  analysis  described  in  the  Methods
section identified only 31 sequences with an FD >1.5. Of
these, 27 (listed in Table 1) are known genes. Approximately
half of the genes were expressed more highly in the inferior
retina, and the other half were expressed more highly in the
superior retina. The FD was greater than two for only two of
the  27  genes  (T  box  5  [Tbx5],  membrane
metalloendopeptidase [Mme]).
Molecular Vision 2010; 16:740-755 <http://www.molvis.org/molvis/v16/a84> © 2010 Molecular Vision
742Functional analysis: The list of 27 genes was subjected to
gene  ontology  analysis,  using  the  bioinformatics  resource
DAVID, which organized the genes into several functional
groups, including Anatomic structure development, Sensory
perception, and Catalytic activity (Table 1). Genes related to
retinal development formed the largest functional group; these
relate to the organization of the retina’s projection to brain
centers.  A  superior-inferior  gradient  is  consistent  with
previous work on these genes [23-25]. Five of the 27 genes
were in the Sensory perception group. Two genes are for short-
and  medium-wavelength  cones;  short-wave-sensitive  cone
opsin1 (Opsn1sw) is more strongly expressed in the inferior
retina, and medium-wave-sensitive cone opsin1 (Opsn1mw)
in the superior retina. These differences in expression match
known  regional  differences  in  the  retinal  distributions  of
short- and medium-length cones [26-28], and confirm the
present separation of inferior and superior retina samples.
Quantitative PCR validation: Six genes were selected for
confirmation of their differential expression in control retinas,
using qPCR (Figure 2). The gene Tbx5 was chosen as an
example  of  the  Anatomic  structure  group,  Opn1sw  and
Opn1mw were chosen as retina-relevant examples from the
Sensory perception group, Mme and somatostatin (Sst) were
chosen  as  a  functionally  inter-related  pair,  and  rhodopsin
(Rho) was chosen as a non-regulated, retina-relevant gene.
Quantitative PCR confirmed the even expression of Rho and
the differential regulation of Mme, Sst, Tbx5, and Opn1sw. For
one gene, Opn1mw (encoding M-opsin), the FD assessed by
qPCR was less than the threshold of 1.5 fold (−1.33 by PCR
versus −1.64 by microarray). However, the difference was in
the same direction in the qPCR and microarray assessments.
Hyperoxia-exposed  retina:  genes  differently  regulated  in
inferior and superior regions: Genes whose regulation by
hyperoxia  differed  significantly  between  the  inferior  and
superior retina could include genes regulated in one region but
not  the  other,  genes  upregulated  in  one  region  and
downregulated in the other, or genes regulated in the same
Figure  1.  Hierarchical  clustering
diagram. The study aims to identify the
genes expressed differently in normoxic
(control)  and  hyperoxic  conditions  in
the superior and inferior halves of the
retina  because  regional  sensitivity  to
hyperoxia of the inferior was expected.
Clustering  analysis  demonstrated
similarity  and  correlation  between
replicates within an experimental group
and  between  different  groups.  Each
column  comprises  a  set  of  horizontal
lines with each line representing a single
gene or noncoding RNA (ncRNA). The
color given to the line depends on the
level of expression of the gene, from
blue  (low  expression)  to  red  (high
expression);  the  range  of  colors
available  is  shown  at  left.  In  each
column, the genes are arranged in low-
to-high  expression,  going  down  the
column. The program then compares the
order  of  genes  in  the  column  and
indicates,  by  the  brackets  at  top,  the
similarities and differences between the
four  samples.  The  replicates  of  each
sample clustered closely to each other
(not  shown)  and  were  averaged  to
constitute the four samples shown. The
samples from the superior retina before
and after hyperoxia were most similar.
The sample from the inferior retina after
hyperoxia,  in  which  photoreceptor
degeneration  was  greatest,  is  most
dissimilar from the other samples.
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744direction in the two regions, but much more strongly in one
region.
Identification: Hyperoxia induced significant changes in gene
expression in both the inferior (hyperoxia-vulnerable) and
superior  (hyperoxia-resistant)  retina,  but  the  number  of
hyperoxia-regulated genes was much higher in the inferior
retina (Figure 3). For example, using the criterion p<0.01 on
the 2-way ANOVA test, the expression of 281 genes and 110
ncRNAs changed significantly in the superior retina, while the
expression of 618 genes and 231 ncRNAs changed in the
inferior retina. Using p≤0.05 and requiring a fold ratio > 2 or
< 0.5, the total number of genes differentially expressed was
over six times greater in the inferior retina than in the superior
retina (58 versus 9). Overall, more genes were upregulated
than downregulated. This imbalance was particularly marked
after applying both selection criteria; for example, 56 genes
were upregulated in the inferior retina, compared to 2 that
were downregulated.
Combining the criteria of p<0.05 and abs (FM) >0.5
(Table 2), a total of 112 sequences with Affymetrix probe IDs
were identified as differently regulated by hyperoxia between
the inferior and superior regions. Of these 112, 97 matched
Figure  2.  Quantitative  PCR  for
microarray validation. Array validation
was performed by quantitative RT–PCR
for  5  genes  selected  from  the  list  in
Table 1. Rhodopsin was used as a retina-
relevant reference gene. qPCR is found
in excellent agreement with the outcome
of microarray analysis. The results of
qPCR  were  averaged  from  three
independent experiments, with the error
bar indicating the standard error of the
mean. Dashed lines at fold differences
of 1 and −1 indicate no difference of
gene  expression  between  the  inferior
and superior regions.
Figure  3.  Significant  more  genes
regulated  in  the  inferior  than  the
superior  retina  after  hyperoxia.
According  to  the  different  selection
criteria, the number of genes and non-
coding  RNAs  regulated  by  hyperoxia
were assessed and separately elucidated
for  the  superior  and  inferior  regions.
Fold  ratio  (FR)  values  <  0.5  indicate
significant  downregulation  of
expression (at least halved); FR values
> 2 indicate significant upregulation of
expression (more than doubled).
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745known genes (Table 2). The gene with the most significant
FM was Edn2 (endothelin 2), a possible stress response gene.
The expression of gene Edn2 increased 7.02 fold in the inferior
retina, but increased just 1.62 fold in the superior retina after
being exposed to hyperoxia.
Functional analysis: Ingenuity Pathway Analysis software
was used to identify biologic functions, diseases, and well
characterized pathways that are most relevant to the genes of
interest.  The  program  compared  the  genes  identified  as
differentially  regulated  between  the  inferior  and  superior
retina  with  a  database  of  genes  involved  in  particular
functions,  diseases,  and  pathways.  It  then  calculated  the
probability  that  each  function,  disease,  or  pathway  is  not
involved  in  the  differential  regulation.  Using  the  criteria
p<0.001  and  a  minimum  involvement  of  five  genes,  the
processes and diseases listed in Table 3 were identified. Some
clusters of differentially regulated genes that possibly impact
photoreceptor vulnerability and survival are listed in Table 4,
arranged according to function, disease, or pathway.
Interestingly, four of the biologic processes identified in
Table 3 are strongly related to the function of the immune
system. Moreover, “immunological disorders” is the disease
category most strongly related to the gene set identified as
differentially regulated by hyperoxia between the inferior and
superior retina.
Quantitative PCR validation: Expression changes of 11 genes
were selected for confirmation by qPCR. From these, eight
genes were chosen from Table 2: Edn2, glial fibrillary acidic
protein (Gfap), B-cell leukemia/lymphoma 3 (Bcl-3), nuclear
receptor subfamily 2, group E, member 3 (Nr2e3), wingless-
related MMTV integration site 8A (Wnt8a), lin-7 homolog B
(Lin7a), complement component 3 (C3), and growth arrest
and DNA-damage-inducible 45 beta (Gadd45b). Three other
genes were also chosen for validation: cyclic nucleotide gated
channel alpha 2 (Cnga2), which has a p-value <0.05 but an
FM <0.5, hypoxia inducible factor 1 alpha subunit (Hif1α),
which has shown responses to hypoxia in previous studies
[29,30], and medium-wave-sensitive cone opsin (Opn1mw),
which is a gene known to be expressed by the retina and that
is not hyperoxia-regulated [14].
The regulation changes of these genes observed by qPCR
and in the microarray are shown in Figure 4. The direction of
the  change  was  confirmed  in  six  of  the  eight  genes  that
differentially  regulate  between  the  inferior  and  superior
retina; the exceptions were Wnt8a and Nr2e3. The magnitude
of the FM between the superior and inferior retina was more
dramatic for genes Edn2, Gfap, and Bcl3. For Cnga2, the
upregulation in the superior and downregulation in the inferior
retina were more noticeable; however, the FM between them
was < 0.5, which was consistent with the microarray data. For
Hif1α and Opn1mw, which showed no significant change in
the microarray, upregulation of approximately 30%–50% was
observed by qPCR. However, such upregulation showed no
regional differences. Upregulation of Hif1α by hyperoxia has
been reported previously [14], but the upregulation was time-
dependent, being prominent after three days of exposure, but
not at the 14-day exposure used here.
DISCUSSION
The microarray analysis presented provides an overview of
regional variations in gene expression in the normal retina
before  and  after  hyperoxic  stress.  Further,
immunohistochemical studies will be needed to identify the
sites  at  which  gene  products  are  expressed.  Although
hyperoxia is specifically toxic to photoreceptors, hyperoxia
may regulate genes in any of the several classes of retinal
neurons  and  neuroglia,  and  in  the  endothelium  of  blood
vessels.
Gene  expression  before  hyperoxia:  Comparing  gene
expression  between  the  superior  and  inferior  retina  under
normoxic (control) conditions, two genes showed an FD in
expression of greater than two, and 27 showed an FD of
greater than 1.5. These differences in gene expression are
relatively limited, but may be significant in determining the
relative invulnerability of the superior retina to hyperoxic
damage  and,  conversely,  the  vulnerability  of  the  inferior
retina.
Seven out of the 27 genes (listed in Table 1) are involved
in anatomic structure development (gene ontology GO-term
0009653). Vax2, Tbx5, and ephrin B2 (Efnb2) are important
in eye morphogenesis and are topographic determinants of the
visual projections between the retina and tectum. In vertebrate
development,  the  polarity  of  the  dorsal-ventral  (dorsal-
superior, ventral-inferior) eye axis is determined by spatially
restricted  expression  of  transcription  factors  Vax2  in  the
inferior retina and Tbx5 in the superior retina [24,25]. Efnb2
is an axon guidance molecule expressed in a low-to-high
superior-inferior gradient in the ganglion cell layer [31]. The
expression of Efnb2 and its receptor is regulated by Vax2 and
Tbx5, which in turn control the dorsal-ventral polarity of
retinotectal  projection  [23].  These  developmental  patterns
were detected in the adult retina in the present experiments,
providing evidence that our separation of inferior-superior
retina was accurate.
Five genes are associated with sensory perception (GO-
term  0007600).  They  belong  to  the  rhodopsin-like
superfamily of G-protein-coupled receptors, although they are
involved in distinct sensory systems. Opn1mw encodes the
medium-wave-sensitive cone opsins (expressed in M-cones)
and Opn1sw encodes the short-wave-sensitive cone opsins (S-
cones  or  “blue”  cones).  The  uneven  distribution  of  cone
receptors, with S-cones more numerous in the inferior retina
and M-cones in superior retina, has been described in mice
[27,28] and cats [26]. The expression differences observed
(1.76  for  Opn1sw  in  an  inferior-superior  comparison  and
−1.64  for  Opn1mw)  confirm  the  differences  in  cone
topography detected by immunohistochemistry.
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748The gene showing the largest FD between the superior
and inferior regions of the normoxic retina is Mme, which is
expressed  more  than  twofold  in  the  inferior  retina.  The
product  of  this  gene  is  a  membrane-bound
metalloendopeptidase,  commonly  known  as  neutral
endopeptidase or neprilysin. It has been found in various cell
lines, including endothelial cells and vascular smooth muscle
cells. Mme belongs to a family of zinc metalloproteases [32].
Another member of this family is endothelin converting
enzyme-1 (ECE-1), which shares 58% amino acid homology
with Mme [33]. ECE-1 catalyzes big endothelin to peptide
endothelin  and  plays  a  key  role  in  proteolytic  endothelin
activation [34]. However, the conversion of big endothelins
to their respective endothelin peptides may not solely depend
on  ECE-1.  In  guinea  pig  lung  parenchyma,  Mme  was
suggested to play a role in the conversion to endothelin-1 and
endothelin-2 [35]. Given their structural homology, it is not
surprising that they share functions. As reported previously
[14], endothelin-2 is the most upregulated gene in the whole
retina after two weeks of hyperoxia. In the present study,
endothelin-2 is the most upregulated gene in the vulnerable
inferior retina after hyperoxic exposure. This correlates with
the overexpression of Mme in the inferior retina. Perhaps
Mme is responsible for or at least represents one pathway of
the biosynthesis of endothelin-2 in the inferior retina after
hyperoxic exposure.
Somatostatin is uniquely capable of stimulating Mme
activity in primary cortical neurons [36]. Most interestingly,
the gene encoding somatostatin (Sst) is also expressed more
in the inferior than the superior retina (Table 1). The relatively
high  expression  of  both  Mme  and  Sst  may  provide  some
insight into the vulnerability of the inferior mouse retina. One
possibility is that there is an unknown regulatory peptide that
protects photoreceptors against oxidative damage and is also,
like amyloid beta (Aβ), a substrate of Mme. Upregulation of
Mme might degrade this peptide, reduce its protective action,
and cause the vulnerability of the inferior retina to hyperoxic
stress. Other possibilities include regional variations in retinal
metabolism,  which  in  turn  may  be  observed  in  regional
variations in retinal blood supply. In the rabbit and monkey,
for example, regional variations in the choroidal circulation
(the major source of oxygen supply to photoreceptors) have
been  described,  matching  retinal  specializations  [37].  An
inferior-superior difference in the retinal circulation has also
been observed in humans [38].
Another established difference between the superior and
inferior retina is environmentally determined. When animals
are raised (as in the present experiments) in light from sources
in the ceiling of a room, the inferior retina is more exposed to
ambient light and is more resistant to subsequent light stress
[17]. Exposure to modest ambient light can “pre-condition”
the retina, making it resistant to subsequent hyperoxic stress
[39]. However, the relative vulnerability of the inferior retina
clearly cannot be explained by such a mechanism. The current
results provide a starting point for further detailed study and
are a first step in describing the mechanisms involved.
Comparison with previous microarray studies—The
present data show that hyperoxia-induced regulation of genes
occurred  significantly  more  in  the  inferior  retina  in  the
C57BL/6J  mouse  retina  (Figure  3);  the  number  of
TABLE 3. THE “BIOLOGIC PROCESSES” AND “DISEASE AND DISORDER” GROUPINGS OF GENES IDENTIFIED AS DIFFERENTIALLY EXPRESSED
BETWEEN SUPERIOR AND INFERIOR RETINA AFTER EXPOSURE TO HYPEROXIA.
Relevant Functions and Diseases Number of molecules p-value
Biologic process
defense response 22 5.9E-11
immune response 19 2.7E-10
response to external stimulus 13 7.9E-06
immune effector process 8 1.1E-05
regulation of multicellular organismal process 10 2.8E-05
antigen processing and presentation 7 4.0E-05
regulation of immune system process 7 4.6E-05
activation of immune response 6 7.1E-05
response to stress 14 3.2E-04
Disease and disorder
immunological disorder 19 1.5E-08
inflammatory disorder 21 3.1E-08
neurologic disorder 26 2.6E-07
genetic disorder 38 1.1E-06
infectious disorder 10 5.7E-05
respiratory disorder 8 1.2E-04
ophthalmic disorder 7 5.1E-04
The two groupings shown met the criteria of significant relevance (p<0.001) and a minimum involvement of 5 genes from gene
list of interest (Table 2).
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749significantly  regulated  known  genes  identified  was
approximately  sevenfold  greater  in  the  inferior  retina  (58
versus nine). The present data can be compared to the all-
retina  study  of  the  Natoli  group  [14],  who  reported  that
following hyperoxic exposure for 14 days, 77 known genes
were  significantly  regulated,  using  the  same  fold  change
criterion. Of the 9 genes significantly regulated by hyperoxia
in the superior retina in the present study, five (55%) are also
on Natoli et al. and coworkers list of all-retina regulated genes.
Of the 58 genes significantly regulated by hyperoxia in the
inferior  retina,  26  (45%)  are  also  on  the  list  of  all-retina
regulated genes. It was also of interest to compare the inferior-
specific regulated genes (Table 2, 97 known genes) with those
identified by Natoli group as hyperoxia-regulated in their all-
retina analysis. Of the 77 genes identified by Natoli group, 21
(27%) were also in the inferior-specific list, including Bcl3,
C3, Edn2, Gfap, and Gadd45b.
One previous microarray study has described the genes
regulated by light damage in mice using the light-vulnerable
BALB/cJ mouse strain [40]. The authors of that study reported
that 70 genes were upregulated at least twofold. Fourteen of
these 70 genes (20%) also displayed differential expression
change in this study. It is possible that the light vulnerability
of retina in BALB/cJ mice and the hyperoxia vulnerability of
TABLE 4. CLUSTERS OF GENES DIFFERENTIALLY REGULATED BETWEEN INFERIOR AND SUPERIOR RETINA, WITH POSSIBLE IMPACT ON
PHOTORECEPTOR VULNERABILITY AND SURVIVAL.
Symbol Description RefSeq FR (inf) FR (sup) FM
Complement system (p=1.66E-07)
C1qb complement component 1, q subcomponent, beta
polypeptide
NM_009777 4.20 1.45 2.75
C1qc complement component 1, q subcomponent, C
chain
NM_007574 4.21 1.93 2.28
C1qa complement component 1, q subcomponent, alpha
polypeptide
NM_007572 3.69 1.68 2.01
C3ar1 complement component 3a receptor 1 NM_009779 1.96 1.02 0.95
C3 complement component 3 NM_009778 2.23 1.28 0.94
Acute phase response signaling, IL-10 signaling (p=1.8E-04–4.07E-03)
Bcl3 B-cell leukemia/lymphoma 3 NM_033601 3.89 1.48 2.42
Socs3 suppressor of cytokine signaling 3 NM_007707 2.12 1.13 1.00
Stat3 signal transducer and activator of transcription 3 NM_213659 2.40 1.44 0.96
Ophthalmic disorders (p=5.10E-04)
Timp1 tissue inhibitor of metalloproteinase 1 NM_001044384 2.74 1.14 1.61
Ccl3 chemokine (C-C motif) ligand 3 NM_011337 2.46 1.06 1.40
C3ar1 complement component 3a receptor 1 NM_009779 1.96 1.02 0.95
C3 complement component 3 NM_009778 2.23 1.28 0.94
Slc16a12 solute carrier family 16 (monocarboxylic acid
transport)
NM_172838 0.77 1.33 −0.56
Vcan versican NM_001081249 0.91 1.48 −0.57
Nr2e3 nuclear receptor subfamily 2, group E, member 3 NM_013708 0.84 1.45 −0.61
Oxidative stress response (p=1.66E-04)
Mt2, Mt1e metallothionein 2 NM_008630 2.41 1.39 1.02
Mt1, Mt1f metallothionein 1 NM_013602 1.57 1.06 0.51
P value accounts for the probability that each function, disease or pathway is not involved in the differential regulation.
Abbreviations: FR represents fold ratio; FM represents fold margin; inf represents inferior; sup represents superior; RefSeq
represents NCBI reference sequence.
Molecular Vision 2010; 16:740-755 <http://www.molvis.org/molvis/v16/a84> © 2010 Molecular Vision
750the inferior retina of C57BL/6J mice share some common
features and mechanisms.
Endothelin-2: The gene Edn2 that encodes endothelin-2
is the most strongly regulated gene in the inferior retina after
hyperoxic  exposure  and  is  also  the  most  differentially
regulated gene between the inferior and superior retina after
hyperoxic  exposure  (Table  2).  Its  expression  increased
Figure 4. Quantitative PCR validation of
expression  changes  induced  by
exposure  to  hyperoxia  in  a  selected
cohort  of  genes.  For  each  gene,  the
change  was  estimated  in  both  the
superior  and  inferior  retina  by
microarray  analysis  and  qPCR.  The
results  of  qPCR  were  averaged  from
three independent experiments, with the
error bar indicating the standard error of
the mean. Fold ratio values >1 indicate
an upregulation and values <1 indicate
a downregulation. Where FR=1 (dotted
line), expression was unchanged.
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751sevenfold in the inferior retina compared to 1.6 fold in the
superior retina after exposure to hyperoxia.
Endothelin-2 belongs to a family of peptides comprising
endothelin-1,  endothelin-2,  and  endothelin-3  [41].  The
endothelins  are  stress-responsive  regulators  that  work  in
paracrine and autocrine fashion in a variety of organs, with
either  beneficial  or  detrimental  results.  For  example,
endothelin-1 is a potent vasoconstrictor in blood vessels. It
also acts as a mitogen on the vascular smooth muscle and has
been  implicated  in  several  vascular  diseases,  such  as
hypertension and atherosclerosis [42].
Endothelin-2  has  been  found  to  be  produced  in
endothelial cells, the heart, and the kidneys [43,44]. In the
retina, the expression of Edn2 is highly induced in models of
retinitis pigmentosa, retinal detachment, and light damage and
the  increased  production  of  Edn2  is  localized  to
photoreceptors [45]. Photoreceptor-derived Edn2 is suggested
to serve as a stress signal in the signaling cascade between the
photoreceptor  and  Müller  glia  cells.  In  the  presence  of
damaging stress such as excessive light exposure and gene
mutation, Müller glia cells sense the photoreceptor damage
and react by upregulating leukemia inhibitory factor (LIF)
[46]. An increase in leukemia inhibitory factor in turn induces
the expression of Edn2 in photoreceptors. The signal is then
passed back to Müller glia cells by binding Edn2 to endothelin
receptor B (Ednrb), which is expressed on Müller cells. This
positive  feedback  loop  then  stimulates  the  production  of
survival factors, such as fibroblast growth factor 2 (FGF2), in
Müller cells and/or photoreceptors to protect visual cells from
further damage [45,46].
Involvement of the immune system: Misregulation of the
innate  immune  response  and  other  immune-mediated
processes has been suggested to play a role in the development
and progression of retinal degenerative diseases, such as age-
related macular degeneration (AMD), in human patients [47,
48]. The involvement of inflammation and immune-mediated
processes has been suggested, for example, in the formation
of drusen and inflammation triggered by the debris generated
by dying retinal pigment epithelial (RPE) cells, as a factor in
photoreceptor cell death [48].
Complement cascade proteins have been shown to be
upregulated in the AMD retina, showing a strong presence
along the RPE-choroid interface and in drusen, the hallmark
of AMD, suggesting that the activation of the complement
pathway has a potential role in drusen biogenesis and the
etiology  of  AMD  [47].  A  murine  model  of  laser-induced
choroidal  neovascularization  (CNV)  in  C57BL/6J  mice
revealed the deposition of C3 and membrane attack complex
in  the  neovascularizing  tissue.  Complement  depletion  in
C3−/− mice resulted in the inhibition of CNV and a marked
reduction of angiogenic factors [49]. C3a is the bioactive
fragment of complement component C3; a blockade of the
C3a receptors (C3aR) also reduces CNV [50]. In addition, in
the degenerative mouse model rd1, the gene ontology groups,
“defense  response,”  “complement  activity,”  and  “stress
response,”  were  significantly  over-represented  in  the
differentially expressed genes in the degenerative retina. The
classical complement pathway was found to be upregulated
in the rd1 mouse [51]. The complement pathway has also been
implicated in the development of glaucoma and in a model of
ocular hypertension [52,53].
Immune-related  factors  and  pathways  may  thus  be
important in the process of photoreceptor cell death induced
by  hyperoxic  stress.  The  present  data  increase  previous
understanding  of  this  involvement,  but  are  arguably  still
inadequate  to  determine  whether  immune  misregulation
causes or results from cell death induced by hyperoxia.
Retinal disease relevant genes: Seven genes listed in
Table 2 were identified as associated with ophthalmic diseases
and three of them correspond to known retinal disease loci
listed  on  the  RetNet  website  (C3,  versican  [Vcan],  and
Nr2e3). Previous studies reported a significant association
between a polymorphism in the C3 gene and susceptibility to
AMD [54,55]. Wagner syndrome can be caused by a mutation
in  the  human  VCAN  gene,  which  encodes  versican,  a
proteoglycan present in the vitreous body [56]. The syndrome
features peculiar lesions of the vitreous and retina, retinal
detachment, and progressive chorioretinal dystrophy [56,57].
Versican is widely distributed in the extracellular matrix of a
variety of tissues and plays an important role in reducing
oxidant  injury  by  enhancing  cell-matrix  interaction  [58].
Mutations in the human NR2E3 gene, which encodes a retina-
specific nuclear receptor, lead to enhanced S-cone syndrome
and retinitis pigmentosa [59].
Antioxidant genes: Metallothioneins (MTs) are a class of
low molecular weight, cysteine-rich proteins that bind with
copper and zinc. The metallothionein family is composed of
four separately encoded isoforms, known as MT-I, -II, -III,
and -IV [60]. They serve as important regulators of metal
homeostasis and provide cytoprotection in tissues subjected
to oxidative stress as a result of their free radical scavenging
ability [61]. Increased expression of MT has been reported in
various  induced  models  of  retinal  degeneration,  including
light [40], hyperoxia [14], and hypoxia [62]. Metallothioneins
have been shown to protect RPE cells against toxic levels of
cadmium, heme- and iron-induced oxidation, and UV light-
induced apoptosis [63]. As endogenous antioxidants, they also
protect ganglion cells from oxidative stress caused by the
glutamate analog N-methyl-D-aspartic acid (NMDA) [64]. In
this study, expression of Mt1 and Mt2 is more elevated in the
inferior retina that has more tissue damage. The prominence
of antioxidants in the retina’s response to hyperoxia indicates
the importance of free radicals in the damage caused [14].
Conversely, the vulnerability of the inferior retina does not
seem to be due to lack of antioxidants in that region. However,
the  upregulation  of  Mt1  and  Mt2  are  not  sufficient  for
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752protecting the inferior retina against hyperoxia-induced cell
death. This is consistent with previous findings that Mt1 and
Mt2  alone  are  insufficient  for  protecting  photoreceptors
against hyperbaric oxygen-induced cell death [16].
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